Art

J-GLOBAL ID：201402233639457261   Reference number：14A0617535

Signal Detection of hepatitis B and hepatitis C by molecularly-targeted drugs for cancer: Data Mining of FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report database

分子標的抗がん剤によるB型肝炎,C型肝炎の解析-日米の有害事象自発報告データベースを用いて-

Author (5)： INOSE RYO (近畿大 薬) ,  HOSOMI KOICHI (近畿大 薬) ,  PARK Binawool (近畿大 薬) ,  FUJIMOTO MAI (近畿大 薬) ,  TAKADA MITSUTAKA (近畿大 薬)
Material： 医療薬学  (Japanese Journal of Pharmaceutical Health Care and Sciences)
Volume： 40  Issue： 5  Page： 268-277  Publication year： May. 10, 2014 
JST Material Number： Y0888A  ISSN： 1346-342X  CODEN： IYRAA3  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *molecular targeting drug ,...
Semi thesaurus term： rituximab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0617535&from=J-GLOBAL&jstjournalNo=Y0888A") }}

JST classification (3)： Poisoning in general  (GD06010Q) ,  Documentation  (GU01030C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Imatinib

Reference (31)：

• Tsubouchi H, Kumada H, Kiyosawa K, Mochida S, Sakaida I, Tanaka E, Ichida T, Mizokami M, Suzuki K, Yoshiba S, Moriwaki H, Hibi T, Hayashi N, Kokudo N, Fujisawa T, Ishibashi H, Sugawara Y, Yatsuhashi H, Ido A, Takikawa Y, Inoue K, Oketani M, Uto H, Nakayama N, Naiki T, Tada S, Kiso S, Yano K, Endo R, Tanaka Y, Umemura T, Kumagai K, Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection -Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis-, Kanzo, 2009, 50, 38-42.
• Hoofnagle JH, Reactivation of Hepatitis B, Hepatology, 2009, 49, 156-165.
• Fujita T, Signal Detection of Adverse Drug Reactions, Jpn J Pharmacoepidemiol, 2009, 14, 27-36.
• Rothman KJ, Lanes S, Sacks ST, The reporting odds ratio and its advantages over the proportional reporting ratio, Pharmacoepidemiol Drug Saf, 2004, 13, 519-523.
• van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, One R, Egberts AC, A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions, Pharmacoepidemiol Drug Saf, 2002, 11, 3-10.

Terms in the title (7)： 分子標的 ,  抗がん剤 ,  B型肝炎 ,  C型肝炎 ,  解析 ,  米 ,  有害事象自発報告データベース